Widespread statin use under NICE 2014 guidelines

Widespread statin use under NICE 2014 guidelines PharmacoEconomics & Outcomes News 784, p31 - 12 Aug 2017 Widespread statin use under NICE 2014 guidelines Statin treatment would be required by 11.8 million adults in England under the UK NICE 2014 guidelines for cardiovascular risk and lipid modification, according to an article in the British Journal of General Practice. The 2014 update of the NICE guidelines reduced the treatment threshold for statin therapy from the previous 10-year cardiovascular risk level of 20% or over, to 10% or over, for all adults without a previous history of cardiovascular disease. In addition, the guideline update endorsed the QRISK2 algorithm to estimate cardiovascular risk. A cross-sectional study was conducted to investigate risk factor levels required to exceed the risk threshold for statin therapy, and to estimate statin usage, based on the 2014 guidelines. Using data from the Health Survey for England, the 10-year cardiovascular risk for adults aged 30–84 years was estimated by inputting varying combinations of risk factors into the QRISK2 algorithm. Even with optimal risk factor levels, the authors found that the 10-year cardiovascular risk threshold would be exceeded by males between the ages of 60 and 70 years, and by females between the ages of 65 and 75 years, regardless of ethnicity. Under the 2014 NICE guidelines, 11.8 million adults aged 30–84 years in England would require statin therapy, which would represent 37% of this demographic. Almost two-thirds of the 9.8 million people without cardiovascular disease who would require statins under the guidelines were eligible for, but not receiving, statin treatment. Discussing the implications of the findings for practice, the authors highlighted that "even if providing statin therapy to a large part of the population is deemed to be cost-effective, it will still require resources to screen, treat, and monitor the patients who are put on treatment". Ueda P, et al. Application of the 2014 NICE cholesterol guidelines in the English population: a cross-sectional analysis. British Journal of General Practice : 31 Jul 2017. Available from: URL: https://doi.org/10.3399/bjgp17X692141 803263658 1173-5503/17/0784-0001/$14.95 Adis © 2017 Springer International Publishing AG. All rights reserved PharmacoEconomics & Outcomes News 12 Aug 2017 No. 784 http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png PharmacoEconomics & Outcomes News Springer Journals

Widespread statin use under NICE 2014 guidelines

Free
1 page

Loading next page...
1 Page
 
/lp/springer_journal/widespread-statin-use-under-nice-2014-guidelines-55trng7LVf
Publisher
Springer International Publishing
Copyright
Copyright © 2017 by Springer International Publishing AG
Subject
Medicine & Public Health; Pharmacoeconomics and Health Outcomes; Quality of Life Research; Health Economics; Public Health
ISSN
1173-5503
eISSN
1179-2043
D.O.I.
10.1007/s40274-017-4242-y
Publisher site
See Article on Publisher Site

There are no references for this article.

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches

$49/month

Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.

$588

$360/year

billed annually
Start Free Trial

14-day Free Trial